Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silybin-Phytosome in Localized Prostate Cancer
NCT00487721Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Aug 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of silibinin in prostate cancer (PCa) (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Measurable Silibinin Tissue Levels. Started Aug 2006; status: completed.
02
Drugs
silibinin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00487721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487721.